Identification of novel aminopiperidine derivatives for antibacterial activity against Gram-positive bacteria
Hee-Yeol Lee1, Kyung-Mi An1, Juyoung Jung1
1Research Laboratories ILDONG Pharmaceutical Co. Ltd, 20, Samsung 1-ro 1-gil, Hwaseong-si, Gyeonggi-do 18449, Republic of Korea.
Abstract:
We have previously reported amidopiperidine derivatives as a novel peptide deformylase (PDF) inhibitor and evaluated its antibacterial activity against Gram-positive bacteria, but poor pharmacokinetic profiles have resulted in low efficacy in in vivo mouse models. In order to overcome these weaknesses, we newly synthesized aminopiperidine derivatives with remarkable antimicrobial properties and oral bioavailability, and also identified their in vivo efficacy against methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE) and penicillin-resistant Streptococcus pneumoniae (PRSP).
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Production of Antibiotics


